THE REGENTS OF THE UNIVERSITY OF COLORADO; A BODYCORPORATE;THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODYCORPORATE;THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION
发明人:
BENNETT, JEFFREY, L.,OWENS, GREGORY, P.,VERKMAN, ALAN, S.
申请号：
EP12774049
公开号：
EP2699256A4
申请日:
2012.04.23
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
The present invention is directed to antibodies binding to aquaporin 4 (AQP4) and methods of using such antibodies to treat neuromyelitis optica (NMO) either as a monotherapy or in combination with standard NMO therapies such as immunosuppressives or plasmaphersis.
